STAND. COM. REP. NO. 422-12


Honolulu, Hawaii

, 2012


RE: H.B. No. 1964

H.D. 1





Honorable Calvin K.Y. Say

Speaker, House of Representatives

Twenty-Sixth State Legislature

Regular Session of 2012

State of Hawaii




Your Committee on Health, to which was referred H.B. No. 1964 entitled:




begs leave to report as follows:


The purpose of this measure is to ensure affordable medication coverage for persons battling cancer. Specifically, this measure:


(1) Requires insurance providers to reimburse patients for chemotherapy using the percentage cost shares that are applicable to non-generic cancer medications; and


(2) Prohibits insurance providers from increasing enrollee cost sharing for non-generic cancer medications in relation to enrollee cost sharing for other non-generic covered medications.


Hawaii Medical Service Association, Hawaii Public Health Association, and three individuals testified in support of this measure. The Department of Budget and Finance testified in support of the intent of this measure. The Department of Commerce and Consumer Affairs, Hawaii Medical Association, American Cancer Society, and Kaiser Permanente provided comments.


Your Committee has amended this measure by:


(1) Requiring insurance providers to reimburse patients for generic and non-generic chemotherapy medications at the same or lower copayment percentage that is applicable to intravenously administered chemotherapy; and


(2) Making technical, nonsubstantive amendments for clarity, consistency, and style.


As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 1964, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 1964, H.D. 1, and be referred to the Committee on Consumer Protection & Commerce.


Respectfully submitted on behalf of the members of the Committee on Health,